Solventum
SOLV
About: Solventum Corp is a healthcare company developing, manufacturing, and commercializing a portfolio of solutions that leverage deep material science, data science, and digital capabilities to address critical customer and patient needs. The company has four operating segments: MedSurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The company generates the majority of its revenue from the MedSurg segment, which provides wound care and surgical solutions that are intended to accelerate healing, prevent complications, and lower the total cost of care globally.
Employees: 22,000
Fund manager confidence
Based on 2025 Q2 regulatory disclosures by fund managers ($100M+ AUM)
242% more call options, than puts
Call options by funds: $115M | Put options by funds: $33.6M
1.13% more ownership
Funds ownership: 65.1% [Q1] → 66.23% (+1.13%) [Q2]
2% more capital invested
Capital invested by funds: $8.55B [Q1] → $8.69B (+$134M) [Q2]
3% less funds holding
Funds holding: 899 [Q1] → 870 (-29) [Q2]
18% less first-time investments, than exits
New positions opened: 74 | Existing positions closed: 90
18% less funds holding in top 10
Funds holding in top 10: 11 [Q1] → 9 (-2) [Q2]
36% less repeat investments, than reductions
Existing positions increased: 225 | Existing positions reduced: 349
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
4 analyst ratings
|
Wells Fargo
Vik Chopra
|
$82
|
Equal-Weight
Maintained
|
15 Sep 2025 |
|
Jefferies
Michael Toomey
|
$80
|
Hold
Initiated
|
11 Sep 2025 |
|
Piper Sandler
Jason Bednar
|
$94
|
Overweight
Maintained
|
8 Aug 2025 |
|
Morgan Stanley
Patrick Wood
|
$103
|
Overweight
Upgraded
|
15 Jul 2025 |
Financial journalist opinion
Based on 12 articles about SOLV published over the past 30 days
